2017
Specific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6.
Sells E, Pandey R, Chen H, Skovan BA, Cui H, Ignatenko NA. 2017. Specific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6. Neoplasia. 19:396–411. doi:10.1016/j.neo.2017.02.003.
Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset.
Padi SKR, Luevano LA, An N, Pandey R, Singh N, Song JH, Aster JC, Yu X-Z, Mehrotra S, Kraft AS. 2017. Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset. Oncotarget. 8:30199–30216. doi:10.18632/oncotarget.16320.
Translocation of the papillomavirus L2/vDNA complex across the limiting membrane requires the onset of mitosis.
Calton CM, Bronnimann MP, Manson AR, Li S, Chapman JA, Suarez-Berumen M, Williamson TR, Molugu SK, Bernal RA, Campos SK. 2017. Translocation of the papillomavirus L2/vDNA complex across the limiting membrane requires the onset of mitosis. PLoS Pathog. 13:e1006200. doi:10.1371/journal.ppat.1006200.
Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease.
Bruce DW, Stefanski HE, Vincent BG, Dant TA, Reisdorf S, Bommiasamy H, Serody DA, Wilson JE, McKinnon KP, Shlomchik WD, et al. 2017. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. J Clin Invest. 127:1813–1825. doi:10.1172/JCI91816.
False Positive Positron Emission Tomography / Computed Tomography Scans in Treated Head and Neck Cancers.
Cheung MK, Ong SY, Goyal U, Wertheim BC, Hsu CC, Yi SK. 2017. False Positive Positron Emission Tomography / Computed Tomography Scans in Treated Head and Neck Cancers. Cureus. 9:e1146. doi:10.7759/cureus.1146.
Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.
Bauman JE, Cohen E, Ferris RL, Adelstein DJ, Brizel DM, Ridge JA, O’Sullivan B, Burtness BA, Butterfield LH, Carson WE, et al. 2017. Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting. Cancer. 123:1259–1271. doi:10.1002/cncr.30449.
Impact of prone versus supine positioning on small bowel dose with pelvic intensity modulated radiation therapy.
Gonzalez VJ, Hullett CR, Burt L, Rassiah-Szegedi P, Sarkar V, Tward JD, Hazard LJ, Huang YJ, Salter BJ, Gaffney DK. 2017. Impact of prone versus supine positioning on small bowel dose with pelvic intensity modulated radiation therapy. Adv Radiat Oncol. 2:235–243. doi:10.1016/j.adro.2017.01.005.
Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy.
Rogers JE, Bolonesi RM, Rashid A, Elsayes KM, Elbanan MG, Law L, Kaseb A, Shroff RT. 2017. Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy. J Gastrointest Oncol. 8:347–351. doi:10.21037/jgo.2017.03.03.
Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T, Georgieva T. 2017. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease. Circ Res. 120:876–894. doi:10.1161/CIRCRESAHA.116.309727.
High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer.
Patel S, Demanes DJ, Ragab O, Zhang M, Veruttipong D, Nguyen K, Park S-J, Marks L, Pantuck A, Steinberg M, et al. 2017. High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer. Brachytherapy. 16:299–305. doi:10.1016/j.brachy.2016.11.002.
Label-Free Biological and Chemical Sensing Using Whispering Gallery Mode Optical Resonators: Past, Present, and Future.
Su J. 2017. Label-Free Biological and Chemical Sensing Using Whispering Gallery Mode Optical Resonators: Past, Present, and Future. Sensors (Basel). 17. doi:10.3390/s17030540.
Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancer.
Bauman JE, Duvvuri U, Gooding WE, Rath TJ, Gross ND, Song J, Jimeno A, Yarbrough WG, Johnson FM, Wang L, et al. 2017. Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancer. JCI Insight. 2:e90449. doi:10.1172/jci.insight.90449.
Conformational Rigidity and Protein Dynamics at Distinct Timescales Regulate PTP1B Activity and Allostery.
Choy MS, Li Y, Machado LESF, Kunze MBA, Connors CR, Wei X, Lindorff-Larsen K, Page R, Peti W. 2017. Conformational Rigidity and Protein Dynamics at Distinct Timescales Regulate PTP1B Activity and Allostery. Mol Cell. 65:644–658.e5. doi:10.1016/j.molcel.2017.01.014.
Elimination of quiescent slow-cycling cells via reducing quiescence depth by natural compounds purified from Ganoderma lucidum.
Dai J, Miller MA, Everetts NJ, Wang X, Li P, Li Y, Xu J-H, Yao G. 2017. Elimination of quiescent slow-cycling cells via reducing quiescence depth by natural compounds purified from Ganoderma lucidum. Oncotarget. 8:13770–13781. doi:10.18632/oncotarget.14634.
Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer.
Liu G, Pei F, Yang F, Li L, Amin AD, Liu S, Buchan JR, Cho WC. 2017. Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer. Int J Mol Sci. 18. doi:10.3390/ijms18020367.
8 Gy single-fraction radiation for bone metastases: Do the data support a 1-size-fits-all approach?
Gonzalez VJ, Howell K. 2017. 8 Gy single-fraction radiation for bone metastases: Do the data support a 1-size-fits-all approach?. Pract Radiat Oncol. 7:16–18. doi:10.1016/j.prro.2016.08.012.
A basal cell defect promotes budding of prostatic intraepithelial neoplasia.
Wang M, Nagle RB, Knudsen BS, Rogers GC, Cress AE. 2017. A basal cell defect promotes budding of prostatic intraepithelial neoplasia. J Cell Sci. 130:104–110. doi:10.1242/jcs.188177.
A dynamical framework for complex fractional killing.
Ballweg R, Paek AL, Zhang T. 2017. A dynamical framework for complex fractional killing. Sci Rep. 7:8002. doi:10.1038/s41598-017-07422-2.
A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma.
Puvvada SD, Guillén-Rodríguez JM, Rivera XI, Heard K, Inclan L, Schmelz M, Schatz JH, Persky DO. 2017. A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma. Oncology. 93:401–405. doi:10.1159/000479230.
A streamlined method for the design and cloning of shRNAs into an optimized Dox-inducible lentiviral vector.
Frank SB, Schulz VV, Miranti CK. 2017. A streamlined method for the design and cloning of shRNAs into an optimized Dox-inducible lentiviral vector. BMC Biotechnol. 17:24. doi:10.1186/s12896-017-0341-x.
A Topical Zinc Ionophore Blocks Tumorigenic Progression in UV-exposed SKH-1 High-risk Mouse Skin.
Justiniano R, Perer J, Hua A, Fazel M, Krajisnik A, Cabello CM, Wondrak GT. 2017. A Topical Zinc Ionophore Blocks Tumorigenic Progression in UV-exposed SKH-1 High-risk Mouse Skin. Photochem Photobiol. 93:1472–1482. doi:10.1111/php.12794.
Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma.
Kendrick S, Rimsza LM, Scott DW, Slack GW, Farinha P, Tan KL, Persky D, Puvvada S, Connors JM, Sehn L, et al. 2017. Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma. Virchows Arch. 470:113–117. doi:10.1007/s00428-016-2041-7.
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
Oliver KE, Brady WE, Birrer M, Gershenson DM, Fleming G, Copeland LJ, Tewari K, Argenta PA, Mannel RS, Secord AA, et al. 2017. An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience. Gynecol Oncol. 147:243–249. doi:10.1016/j.ygyno.2017.08.004.
Analysis of Transcriptional Variability in a Large Human iPSC Library Reveals Genetic and Non-genetic Determinants of Heterogeneity.
Carcamo-Orive I, Hoffman GE, Cundiff P, Beckmann ND, D’Souza SL, Knowles JW, Patel A, Papatsenko D, Abbasi F, Reaven GM, et al. 2017. Analysis of Transcriptional Variability in a Large Human iPSC Library Reveals Genetic and Non-genetic Determinants of Heterogeneity. Cell Stem Cell. 20:518–532.e9. doi:10.1016/j.stem.2016.11.005.
Angiosarcoma treated successfully with anti-PD-1 therapy - a case report.
Sindhu S, Gimber LH, Cranmer L, McBride A, Kraft AS. 2017. Angiosarcoma treated successfully with anti-PD-1 therapy - a case report. J Immunother Cancer. 5:58. doi:10.1186/s40425-017-0263-0.